Cargando…
A review of the sustainability of vaccine funding across Europe and implications for post-COVID policymaking
BACKGROUND: Approaches to routine vaccine funding and the underlying budget-setting process vary greatly across European countries. The ongoing COVID-19 pandemic has put enormous pressure on healthcare systems, affecting resilience of the overall vaccine ecosystem. METHODS: This article reviews how...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364713/ https://www.ncbi.nlm.nih.gov/pubmed/36008177 http://dx.doi.org/10.1016/j.healthpol.2022.08.004 |
_version_ | 1784765203112525824 |
---|---|
author | Lawlor, Ryan Wilsdon, Tim Rémy-Blanc, Vanessa Nogal, Agustín Álvarez Pana, Adrian |
author_facet | Lawlor, Ryan Wilsdon, Tim Rémy-Blanc, Vanessa Nogal, Agustín Álvarez Pana, Adrian |
author_sort | Lawlor, Ryan |
collection | PubMed |
description | BACKGROUND: Approaches to routine vaccine funding and the underlying budget-setting process vary greatly across European countries. The ongoing COVID-19 pandemic has put enormous pressure on healthcare systems, affecting resilience of the overall vaccine ecosystem. METHODS: This article reviews how vaccine budgets are structured across 8 European countries (England, Finland, France, Germany, Italy, Norway, Romania, and Spain). First a literature review of the landscape was undertaken, followed by expert interviews to review the findings and consider policy principles to secure prioritisation and sustainability of routine vaccination budgets post-COVID. RESULTS: The organisation of budgets and vaccine spending varies greatly across Europe. In 2/8 countries (France and Germany) vaccine spending is subsumed into a wider healthcare budget. In 2/8 countries (Italy and Romania) the budget differentiates public health and prevention spending from other areas of healthcare, though there is no standalone vaccine budget. In 4/8 countries (England, Finland, Norway and Spain) there is a standalone vaccine budget, however this may not cover all elements needed for immunisation delivery and is not always transparent. CONCLUSION: Ensuring adequate and dynamic country vaccine budgets, with horizon scanning approaches like in England and Finland, or flexible vaccines expenditures like Germany, would greatly help the timely availability of public funding for new vaccines and strengthen vaccines supply security in Europe through a more virtuous European vaccine ecosystem. |
format | Online Article Text |
id | pubmed-9364713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Authors. Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93647132022-08-10 A review of the sustainability of vaccine funding across Europe and implications for post-COVID policymaking Lawlor, Ryan Wilsdon, Tim Rémy-Blanc, Vanessa Nogal, Agustín Álvarez Pana, Adrian Health Policy Article BACKGROUND: Approaches to routine vaccine funding and the underlying budget-setting process vary greatly across European countries. The ongoing COVID-19 pandemic has put enormous pressure on healthcare systems, affecting resilience of the overall vaccine ecosystem. METHODS: This article reviews how vaccine budgets are structured across 8 European countries (England, Finland, France, Germany, Italy, Norway, Romania, and Spain). First a literature review of the landscape was undertaken, followed by expert interviews to review the findings and consider policy principles to secure prioritisation and sustainability of routine vaccination budgets post-COVID. RESULTS: The organisation of budgets and vaccine spending varies greatly across Europe. In 2/8 countries (France and Germany) vaccine spending is subsumed into a wider healthcare budget. In 2/8 countries (Italy and Romania) the budget differentiates public health and prevention spending from other areas of healthcare, though there is no standalone vaccine budget. In 4/8 countries (England, Finland, Norway and Spain) there is a standalone vaccine budget, however this may not cover all elements needed for immunisation delivery and is not always transparent. CONCLUSION: Ensuring adequate and dynamic country vaccine budgets, with horizon scanning approaches like in England and Finland, or flexible vaccines expenditures like Germany, would greatly help the timely availability of public funding for new vaccines and strengthen vaccines supply security in Europe through a more virtuous European vaccine ecosystem. The Authors. Published by Elsevier B.V. 2022-10 2022-08-10 /pmc/articles/PMC9364713/ /pubmed/36008177 http://dx.doi.org/10.1016/j.healthpol.2022.08.004 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Lawlor, Ryan Wilsdon, Tim Rémy-Blanc, Vanessa Nogal, Agustín Álvarez Pana, Adrian A review of the sustainability of vaccine funding across Europe and implications for post-COVID policymaking |
title | A review of the sustainability of vaccine funding across Europe and implications for post-COVID policymaking |
title_full | A review of the sustainability of vaccine funding across Europe and implications for post-COVID policymaking |
title_fullStr | A review of the sustainability of vaccine funding across Europe and implications for post-COVID policymaking |
title_full_unstemmed | A review of the sustainability of vaccine funding across Europe and implications for post-COVID policymaking |
title_short | A review of the sustainability of vaccine funding across Europe and implications for post-COVID policymaking |
title_sort | review of the sustainability of vaccine funding across europe and implications for post-covid policymaking |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364713/ https://www.ncbi.nlm.nih.gov/pubmed/36008177 http://dx.doi.org/10.1016/j.healthpol.2022.08.004 |
work_keys_str_mv | AT lawlorryan areviewofthesustainabilityofvaccinefundingacrosseuropeandimplicationsforpostcovidpolicymaking AT wilsdontim areviewofthesustainabilityofvaccinefundingacrosseuropeandimplicationsforpostcovidpolicymaking AT remyblancvanessa areviewofthesustainabilityofvaccinefundingacrosseuropeandimplicationsforpostcovidpolicymaking AT nogalagustinalvarez areviewofthesustainabilityofvaccinefundingacrosseuropeandimplicationsforpostcovidpolicymaking AT panaadrian areviewofthesustainabilityofvaccinefundingacrosseuropeandimplicationsforpostcovidpolicymaking AT lawlorryan reviewofthesustainabilityofvaccinefundingacrosseuropeandimplicationsforpostcovidpolicymaking AT wilsdontim reviewofthesustainabilityofvaccinefundingacrosseuropeandimplicationsforpostcovidpolicymaking AT remyblancvanessa reviewofthesustainabilityofvaccinefundingacrosseuropeandimplicationsforpostcovidpolicymaking AT nogalagustinalvarez reviewofthesustainabilityofvaccinefundingacrosseuropeandimplicationsforpostcovidpolicymaking AT panaadrian reviewofthesustainabilityofvaccinefundingacrosseuropeandimplicationsforpostcovidpolicymaking |